Heal.Med CIC

HEAL.med CIC is a not-for-profit Community Interest Company set up to deliver knowledge and education to support children and young people with type 1 diabetes.

Scale up operations and trade internationally.



  • Internationalisation of their education is still in a research and viability stage, but there is significant interest coming from all over the world. They are aiming for further roll-out in 2023/2024.
  • Specialist Networking Grant to attend , the Friends for Life (FFL) USA Diabetes Conference, allowing HEAL.med to showcase their app and educational resources to the US market.

     

“By supporting us to attend the Friends for Life Conference in the USA, Medilink Midlands and the SoLSTICE project allowed us to ensure that we remain at the forefront of diabetes education. This, coupled with our future international expansion plans, means that we are in a far better position than we would have otherwise been, to expand internationally and deliver diabetes education across the world.” 

Lee Paxman-Clarke, CEO

Latest Opportunities

Single manufacturer & supplier required for human skin patch: Formulation, manufacture, and packing

Opportunity Company:  Nottingham-based MedTech company Requires: Seeking a single manufacturer and supplier for the formulation,…

Medilink Midlands Job Vacancy - Innovation Adviser

About the job Innovation Adviser – Midlands region – Full time salary £40-45K – Home…

Global Business Innovation Programme: Health & Medical Technologies - Singapore

Innovate UK is inviting ambitious innovative companies to participate in its Global Business Innovation Programme…

Latest News

Cambridge Sleep Sciences Unveils World-First Performance Pillow That Adapts to Users’ Sleep

Cambridge Sleep Sciences Unveils World-First Performance Pillow That Adapts to Users’ Sleep – Helping Gamers…

Kindeva Opens New UK HQ and Manufacturing Site for the Development of Next-Generation Propellants

Kindeva, a global CDMO and drug delivery expert, has officially opened its new UK headquarters…

EU MDR/IVDR Revision: A Gateway for Chinese Innovators Entering UK and EU Markets via EFEC

In a significant move for the global medtech landscape, the European Commission has initiated a…